How a Biomarker Test Saved This Lung Cancer Survivor’s Life
byCOVID-19-
Brittany Hawkins was diagnosed with stage IV lung cancer and given 3-6 months to live. Then a biomarker test led to targeted treatment that changed everything.
Brittany Hawkins was diagnosed with stage IV lung cancer and given 3-6 months to live. Then a biomarker test led to targeted treatment that changed everything.